CN109771635A - A kind of preparation method adjusting women Bacillus acidi lactici microecological balance Chinese medicine composition - Google Patents

A kind of preparation method adjusting women Bacillus acidi lactici microecological balance Chinese medicine composition Download PDF

Info

Publication number
CN109771635A
CN109771635A CN201711110311.3A CN201711110311A CN109771635A CN 109771635 A CN109771635 A CN 109771635A CN 201711110311 A CN201711110311 A CN 201711110311A CN 109771635 A CN109771635 A CN 109771635A
Authority
CN
China
Prior art keywords
radix glycyrrhizae
oligosaccharide
glucose
acidi lactici
bacillus acidi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711110311.3A
Other languages
Chinese (zh)
Inventor
程淑清
牛清玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Xiu Feng Biological Technology Co Ltd
Original Assignee
Shaanxi Xiu Feng Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi Xiu Feng Biological Technology Co Ltd filed Critical Shaanxi Xiu Feng Biological Technology Co Ltd
Priority to CN201711110311.3A priority Critical patent/CN109771635A/en
Publication of CN109771635A publication Critical patent/CN109771635A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A kind of preparation method adjusting women Bacillus acidi lactici microecological balance Chinese medicine composition is technical field of pharmaceuticals.Radix Glycyrrhizae ribosome inactivating protein is used to prepare to the drug for increasing Bacillus acidi lactici quantity in woman vagina as active component.Composition is with Radix Glycyrrhizae ribosome inactivating protein, mannosan, oligosaccharide or/and glucose, Bletilla glucomannan, or being further added by Radix Codonopsis, barberry and Rhizoma Atractylodis Macrocephalae extract is active component, relative weight share are as follows: 0.5~1.0 part of Radix Glycyrrhizae ribosome inactivating protein, 1.5~3.0 parts of mannosan, oligosaccharide or/and 0.2~2.0 part of glucose, 0.2~0.5 part of Bletilla glucomannan, one of Radix Codonopsis dry powder, barberry dry powder and Rhizoma Atractylodis Macrocephalae dry powder or more than one totally 1.0~3.0 parts of resulting extracts.It can be water-soluble complex liquid, wherein preferably gelling agent;It is also possible to the pharmaceutical dosage form that solid dosage forms such as suppository, disintegrated tablet etc. is suitable for external application.Compared to the prior art, products obtained therefrom does not need to save at low temperature, and the resting period is long, easy to use.

Description

A kind of preparation method adjusting women Bacillus acidi lactici microecological balance Chinese medicine composition
Technical field
The present invention is technical field of pharmaceuticals.
Background technique
The micropopulation for parasitizing healthy women intravaginal mainly has bacterium, fungi, protozoon and virus.They mainly dwell The mucous membrane gauffer of vagina and fornix portion, followed by uterine neck.The main permanent bacterium of intravaginal has Bacillus acidi lactici, epidermis grape ball Bacterium, Escherichia coli, corynebacteria, B race streptococcus, streptococcus fecalis, mycoplasma, Candida albicans, peptococcus and bacteroid etc. Deng.Mutually restriction, mutually coordinated, dynamic yin are constituted between a variety of microflora groups of intravaginal and host, environment Road microecological balance.The microecological balance of vagina plays an important role to the self purification and the healthy of host that maintain it.When Sharply decline of the host due to using broad-spectrum antibiotic, ovarian function, vagina caused by the factors such as surgical operation, external force and childbirth Damage, radioactive ray and immunosuppressor the reasons such as excessively use, cause the habitat of vagina that change dramatically occurs, can destroy it Microecological balance leads to the flora imbalance of vagina.Easily cause the infectious diseases of vagina at this time, the main source of infection is yin Conditioned pathogen in road Tiny ecosystem group, such as Escherichia coli, bacteroid, peptococcus, staphylococcus aureus, B race hammer Bacterium, Candida albicans, trichomonad and mycoplasma etc..Vaginal dysbacteriosis is mainly shown as various types of vaginitis.
Antibiotic, metronidazole, estrogen and acidification vagina are mainly used for the remedy measures of such disease at present Preparation kill the pathogenic microorganism of intravaginal, but effect is undesirable.
Generally measuring viable count in healthy women vaginal discharge with qualitative and quantitative method is 102-9/ml, anaerobic bacteria Ratio with aerobic bacteria is 5: 1.Wherein Bacillus acidi lactici is the permanent bacterium of most important, quantity at most in vagina normal flora, number Amount accounts for 95% or more, up to 8 × 107/ml.Bacillus acidi lactici plays an important role in maintaining microecology in vaginas balance, it is decomposable The intracellular glycogen of vaginal mucosal epithelium, generates a certain amount of lactic acid, so that vagina is kept acidic environment, is conducive to the self-cleaning of vagina Effect.The immune function of body can be improved in it simultaneously, and activating macrophage maintains the anti-infection ability of vagina part.Furthermore it Also have the function of preventing cervicovaginal epithelial metaplasia.(Wang Lisheng, Pan Lingjia, Zhou Dianyuan China microecology magazine .1998, 10 (5): 300-302.).Using probiotics made of the Bacillus acidi lactici in vagina normal microflora to this kind of illness Prophylactic treatment and health care achieve preferable effect.Currently, there are many using system made of Bacillus acidi lactici on domestic and international market Agent is as determined monarch's life, lactic acid bacteria capsule etc..But since viable bacteria body needs to save at low temperature, the resting period is short, for practical application Inconvenience, especially out of town trip etc..
Application No. is 2011101840614 Chinese patent documents to disclose " a kind of human body external compound preparation and its use On the way ", first invention people i.e. the first invention people of present patent application.The compound preparation is with phytolectin (PHA) and sweet Dew glycan is active component, plays contraception, prevention and treatment sexually transmitted disease and lubrication, and effect is not to increase in woman vagina Bacillus acidi lactici quantity maintains microecological balance.
Summary of the invention
The purpose of the present invention: providing a kind of preparation method for adjusting women Bacillus acidi lactici microecological balance Chinese medicine composition, Main function is Bacillus acidi lactici quantity in increase woman vagina, maintains microecological balance, and product does not need to save at low temperature, Resting period is long, easy to use.
Purposes invention, which is characterized in that for Radix Glycyrrhizae ribosome inactivating protein being used to prepare as active component, increases women's yin The drug of Bacillus acidi lactici quantity in road.And the weight content of Radix Glycyrrhizae ribosome inactivating protein is preferably thousand points of medicine gross weight One of.
Pharmaceutical composition of the present invention is with Radix Glycyrrhizae ribosome inactivating protein, mannosan, oligosaccharide or/and glucose, white Splendid achnatherum glue is active component, the relative weight share in composition between contained above-mentioned active component are as follows: Radix Glycyrrhizae RIP activity egg White 0.5~1.0 part, 1.5~3.0 parts of mannosan, oligosaccharide or/and 0.2~2.0 part of glucose, 0.2~0.5 part of Bletilla glucomannan; Either with Radix Glycyrrhizae ribosome inactivating protein, mannosan, oligosaccharide or/and glucose, Bletilla glucomannan, Radix Codonopsis extract, three Needle extract, Rhizoma Atractylodis Macrocephalae extract are active component, the relative weight share in composition between contained above-mentioned active component are as follows: sweet 0.5~1.0 part of careless ribosome inactivating protein, 1.5~3.0 parts of mannosan, oligosaccharide or/and 0.2~2.0 part of glucose are white 0.2~0.5 part of splendid achnatherum glue, one of Radix Codonopsis dry powder, barberry dry powder and Rhizoma Atractylodis Macrocephalae dry powder or more than one totally 1.0~3.0 parts of institutes The extract obtained.Described Radix Glycyrrhizae ribosome inactivating protein can be white Radix Glycyrrhizae ribosome inactivating protein, be also possible to Radix Glycyrrhizae Ribosome inactivating protein.
Described Radix Codonopsis, barberry and the resulting extract of Rhizoma Atractylodis Macrocephalae dry powder are preferably the extract that water extraction generates, in these Medicine plant extracts is all made of medium temperature extraction method at the extraction, i.e., temperature is maintained always between 40~60 DEG C in extraction process.
The dosage form of natural drug composition of the present invention can be water-soluble complex liquid, wherein preferably gelling agent;It can also To be the pharmaceutical dosage form suitable for external application such as solid dosage forms such as suppository, disintegrated tablet.
Natural drug composition of the present invention is mainly used for increasing Bacillus acidi lactici quantity in woman vagina, but can also be used for human body The prevention and treatment of other illness, such as the treatment of wound.
Natural drug composition coagulant liquid of the present invention is characterized in that in 100ml coagulant liquid containing following component:
0.5~1.0 gram of Radix Glycyrrhizae ribosome inactivating protein,
1.5~3.0 grams of mannosan,
Oligosaccharide or/and 0.5~2.0 gram of glucose,
0.2~0.5 gram of Bletilla glucomannan,
NaCl0.8~0.9 gram,
PH buffer is pharmaceutically coagulant liquid acceptable amount,
Stabilizer is pharmaceutically coagulant liquid acceptable amount,
Preservative is pharmaceutically coagulant liquid acceptable amount;
Either contain following component in 100ml coagulant liquid:
0.5~1.0 gram of Radix Glycyrrhizae ribosome inactivating protein,
1.5~3.0 grams of mannosan,
Oligosaccharide or/and 0.5~2.0 gram of glucose,
0.2~0.5 gram of Bletilla glucomannan,
One of Radix Codonopsis dry powder, barberry dry powder and Rhizoma Atractylodis Macrocephalae dry powder or more than one totally 1.0~3.0 grams of resulting water mention Object is taken,
NaCl0.8~0.9 gram,
PH buffer is pharmaceutically coagulant liquid acceptable amount,
Stabilizer is pharmaceutically coagulant liquid acceptable amount,
Preservative is pharmaceutically coagulant liquid acceptable amount.
Described Radix Glycyrrhizae ribosome inactivating protein can be white Radix Glycyrrhizae ribosome inactivating protein, be also possible to Radix Glycyrrhizae ribose Body inactivating protein.
Medicaments compound is the pathological state for body, emphasizes organic cooperation of each component and dosage, carries out multiple location, Multiple target point, the structure adjusting of multipath, to restore the equilibrium state of body.
Natural drug composition emphasis of the present invention is directed to the Bacillus acidi lactici in close relations with women's health, divides using from Radix Glycyrrhizae Radix Glycyrrhizae ribosome inactivating protein and oligosaccharide (oligosaccharide or/and glucose) from extraction are key component, are added with other from day The effective ingredient extracted in right product or Chinese herbal medicine, preparing to become has promotion Vaginal lactobacilli growth, inhibits and killing has Evil microorganism includes bacterium, the preparation of fungi and virus and other effects, and supplements natural estrogen, prevents from infecting, repairs wound, most The nature restored based on Bacillus acidi lactici is realized eventually.Prove the product to BV (bacterial vaginosis BV), VVC through practical application (vulvovaginal candidiasis), BP (bowenoid papulosis), HPV (human papilloma virus) and inhibition of HIV all have inhibition With killing function.Product of the present invention, which is removed, optionally promotes one or more of beneficial bacterial metabolics containing oligosaccharide and glucose etc. With breeding, into except the component of host health, also contain phytolectin, they have Bacillus acidi lactici and Bifidobacterium breeding Apparent facilitation.Therefore, product of the present invention is a kind of novel, while carrying probiotics " grain ", oligosaccharide and breeding The compound formulation of the PHA of (division) promotor, function and effect are more much more obvious than individual prebiotics.
Oligosaccharide (oligosaccharide or/and glucose) and Bletilla glucomannan are added, the purpose is to enhance repairing for natural drug composition Reactivation power and the ability for combining skin and mucous membrane;In addition, Bletilla glucomannan itself also has certain bacteriostasis.
Natural drug composition coagulant liquid of the present invention can use in this way: under normal circumstances, with without Radix Codonopsis, barberry and The coagulant liquid (abbreviation coagulant liquid A) plus water of Rhizoma Atractylodis Macrocephalae ingredient make daily cleaning nursing;Occur first using coagulant liquid A when illness, works as disease Without the gel containing Radix Codonopsis, barberry and Rhizoma Atractylodis Macrocephalae ingredient usable when mitigating when shape is heavier or using symptom after coagulant liquid A 48h Liquid (abbreviation coagulant liquid B).White Radix Glycyrrhizae used or Radix Glycyrrhizae ribosome inactivating protein are special in following experiment and embodiment Sharp applicant laboratory produces in white Radix Glycyrrhizae and Radix Glycyrrhizae from Yunnan extracts.
The principle that product of the present invention Tiny ecosystem maintained and increased Bacillus acidi lactici quantity is:
1. the pH of solution is 4.0~4.5, there is inhibiting effect to most of microorganisms for causing BV, and this pH value is suitble to The growth of Bacillus acidi lactici;
2. phytolectin is a kind of mitogen, it has been found that Radix Glycyrrhizae ribosome inactivating protein is dense in above-mentioned formula It can promote lactobacillus growth under degree;
3. also containing oligosaccharide (oligosaccharide and glucose) in solution, in this way, right as the nutriment of Bacillus acidi lactici Bacillus acidi lactici plays the role of nutritional support;
4. also containing estrogen licoisoflavanone in Radix Glycyrrhizae ribosome inactivating protein extracting solution, related research both domestic and external is aobvious Show, senile vaginitis patients can reverse the atrophy of vaginal wall to change and alleviate symptom using estrogen, the supplement of estrogen The thickness of vagina epithelium, the elasticity of vaginal wall are increased, vaginal pH is reduced, has restored the self purification of vagina;
5. phytolectin can stimulate lymphocyte to generate interferon and interleukins.
Beneficial effects of the present invention: compared to the prior art, products obtained therefrom does not need to save at low temperature, the resting period It is long, it is easy to use.
Specific embodiment
Embodiment
Add barberry again on the basis of being formulated A, the extract of Radix Codonopsis or Rhizoma Atractylodis Macrocephalae etc. becomes formula B.Be formulated B be Contain in 100 milliliters of coagulant liquids:
0.5 gram of phytolectin,
2.0 grams of mannosan,
Oligosaccharide (total amount of oligosaccharide and glucose) 0.5g,
0.2 gram of Bletilla glucomannan,
Radix Codonopsis dry powder, barberry dry powder and each 1.0 grams of Rhizoma Atractylodis Macrocephalae dry powder, totally 3.0 grams of resulting water extracts, NaCl 0.85 Gram,
PH buffer: citric acid-disodium hydrogen phosphate buffer (pH4.0).Solution A: citric acid 21g or anhydrous citric acid are taken 19.2g adds water to make to be dissolved into 1000ml, sets in refrigerator and saves.Second liquid: taking disodium hydrogen phosphate 71.63g, and water is added to make to be dissolved into 1000ml. takes above-mentioned solution A 61.45ml to mix with second liquid 38.55ml, shake up to get,
Stabilizer: 3.0 grams of mannose,
Preservative: 0.15 gram of ethyl ester sodium,
PH value is 4.5-4.7.

Claims (2)

1. a kind of preparation method for adjusting women Bacillus acidi lactici microecological balance Chinese medicine composition, it is characterised in that: plant Radix Glycyrrhizae Object agglutinin is used to prepare the drug for increasing Bacillus acidi lactici quantity in woman vagina as active component.
2. a kind of pharmaceutical composition, it is characterised in that:
Using Radix Glycyrrhizae ribosome inactivating protein, mannosan, oligosaccharide or/and glucose, Bletilla glucomannan as active component, active component Between relative weight share are as follows: 0.5~1.0 part of Radix Glycyrrhizae ribosome inactivating protein, 1.5~3.0 parts of mannosan, oligosaccharide Or/and 0.2~2.0 part of glucose, 0.2~0.5 part of Bletilla glucomannan;
Either with Radix Glycyrrhizae ribosome inactivating protein, mannosan, oligosaccharide or/and glucose, Bletilla glucomannan, Radix Codonopsis extract, Radix Berberidis extract, Rhizoma Atractylodis Macrocephalae extract are active component, the relative weight share between active component are as follows: Radix Glycyrrhizae RIP activity 0.5~1.0 part of albumen, 1.5~3.0 parts of mannosan, oligosaccharide or/and 0.2~2.0 part of glucose, Bletilla glucomannan 0.2~0.5 Part, one of Radix Codonopsis dry powder, barberry dry powder and Rhizoma Atractylodis Macrocephalae dry powder or more than one totally 1.0~3.0 parts of resulting extracts.
CN201711110311.3A 2017-11-12 2017-11-12 A kind of preparation method adjusting women Bacillus acidi lactici microecological balance Chinese medicine composition Pending CN109771635A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711110311.3A CN109771635A (en) 2017-11-12 2017-11-12 A kind of preparation method adjusting women Bacillus acidi lactici microecological balance Chinese medicine composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711110311.3A CN109771635A (en) 2017-11-12 2017-11-12 A kind of preparation method adjusting women Bacillus acidi lactici microecological balance Chinese medicine composition

Publications (1)

Publication Number Publication Date
CN109771635A true CN109771635A (en) 2019-05-21

Family

ID=66485465

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711110311.3A Pending CN109771635A (en) 2017-11-12 2017-11-12 A kind of preparation method adjusting women Bacillus acidi lactici microecological balance Chinese medicine composition

Country Status (1)

Country Link
CN (1) CN109771635A (en)

Similar Documents

Publication Publication Date Title
CN110016442B (en) Application of lactobacillus rhamnosus and compound bacterium powder thereof in product for preventing and treating vaginitis
EP3520785B1 (en) Uses of bacteriostatic agent formula in preparing composition for vaginal use and composition for vaginal use
CN101797304B (en) Gel for adjusting microecology in vaginas of women
CN103409334B (en) Inhibit the Bacillus acidi lactici and application thereof of vaginitis pathogen
CN103157095B (en) Kidney bean phytolectin applications in preparation of human drugs and drug composition thereof
WO2006001766A1 (en) Composition comprising lactic acid and lactoferrin
CN110090195A (en) A kind of women secret nursing gel and preparation method thereof
CN109394794A (en) The composite probiotics preparations and preparation method of prophylactic treatment gynecological disease and application
CN104870002A (en) Chitin or derivatives thereof for the prevention and/or treatment of parasitoses
CN108042578A (en) A kind of health care vaginal jellies containing compound probiotic ingredient
CN101797269B (en) Physiological balance liquid for adjusting microecology in vaginas of women
CN114588253A (en) Pharmaceutical composition for repairing and preventing vaginal mucosa aging and preparation thereof
CN109985069B (en) Probiotic compositions and uses thereof
RU2723015C2 (en) Composition for maintenance of lactobacteria domination
CN110585418A (en) External use disinfection essential oil emulsion for women and production process thereof
CN104069124A (en) Composition and preparation for gynecologic infections
CN109464655B (en) External capsule preparation for preventing and treating vaginitis
CN115517367B (en) Application of lactobacillus paracasei SMN-LBK in preparation of intestinal health promoting product
CN109771635A (en) A kind of preparation method adjusting women Bacillus acidi lactici microecological balance Chinese medicine composition
CN109771639A (en) The application method of Radix Glycyrrhizae ribosome inactivating protein in medicine preparation
CN109771636A (en) A method of preparation Traditional Chinese drug microecology composition is extracted by Radix Glycyrrhizae
CN102048729A (en) Preparation for treating vaginitis
CN112057601B (en) Preparation method of active probiotic freeze-dried powder and application of active probiotic freeze-dried powder in skin and gynecological diseases
CN105534948B (en) A kind of vagina active bacteria formulation and preparation method thereof being stored at room temperature
WO2017193509A1 (en) Bionic gynecological lotion and preparation method therefor

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190521

WD01 Invention patent application deemed withdrawn after publication